Daniel Carretero-Molina

Mr. Daniel Carretero-Molina

Fundación MEDINA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Daniel Carretero-MolinaDaniel Carretero-Molina
Daniel Carretero-Molina
FOFrancisco Javier Ortiz-López
Francisco Javier Ortiz-López
JSJesús Martín Serrano
Jesús Martín Serrano
DODaniel Oves-Costales
Daniel Oves-Costales
CNCaridad Díaz Navarro
Caridad Díaz Navarro
Fernando ReyesFernando Reyes
Fernando Reyes
As part of our continuing efforts to discover new bioactive compounds from microbial sources, a reinvestigation of extracts of scaled-up cultures of the marine-derived Streptomyces sp. strain CA-271078 resulted in the isolation and structural elucidation of four new napyradiomycins (1–3, 5). The known napyradiomycin SC (4), whose structural details had not been previously described in detail, and another ten related known compounds (6–15). The structures of the new napyradiomycins were characterized by HRMS and 1D- and 2D-NMR spectroscopies and their relative configurations were established through a combination of molecular modelling with nOe and coupling constants NMR analysis. The absolute configuration of each compound is also proposed based on biosynthetic arguments and the comparison of specific rotation data with those of related compounds. Among the new compounds, 1 was determined to be the first non-halogenated member of napyradiomycin A series containing a functionalized prenyl side chain, while 2–4 harbor in their structures the characteristic chloro-cyclohexane ring of the napyradiomycin B series. Remarkably, compound 5 displays an unprecedented 14-membered cyclic ether ring between the prenyl side chain and the chromophore, thus representing the first member of a new class of napyradiomycins that we have designated as napyradiomycin D1. Anti-infective and cytotoxic properties for all isolated compounds were evaluated against a set of pathogenic microorganisms and the HepG2 cell line, respectively. Among the new compounds, napyradiomycin D1 exhibited significant growth-inhibitory activity against methicillin-resistant Staphylococcus aureus, Mycobacterium tuberculosis, and HepG2.

6 April 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
MAMohammed Aldholmi
Mohammed Aldholmi
RARizwan Ahmad
Rizwan Ahmad
Daniel Carretero-MolinaDaniel Carretero-Molina
Daniel Carretero-Molina
Ignacio Pérez-VictoriaIgnacio Pérez-Victoria
Ignacio Pérez-Victoria
JSJesús Martín Serrano
Jesús Martín Serrano
A GanesanA Ganesan
A Ganesan
By limiting the nitrogen source to glutamic acid, we isolated cyclic peptides from Euglena gracilis containing asparagine and non‐proteinogenic amino acids. Structure elucidation was accomplished through spectroscopic methods, mass spectrometry and chemical degradation. The euglenatides potently inhibit pathogenic fungi and cancer cell lines e.g., euglenatide B exhibiting IC50 values of 4.3 μM in Aspergillus fumigatus and 0.29 μM in MCF‐7 breast cancer cells. In an unprecedented convergence of non‐ribosomal peptide synthetase and polyketide synthase assembly‐line biosynthesis between unicellular species and the metazoan kingdom, euglenatides bear resemblance to nemamides from Caenorhabditis elegans and inhibited both producing organisms E. gracilis and C. elegans. By molecular network analysis, we detected over forty euglenatide‐like metabolites in E. gracilis, E. sanguinea and E. mutabilis, suggesting an important biological role for these natural products.

30 October 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Charlotte BeckCharlotte Beck
Charlotte Beck
TGTetiana Gren
Tetiana Gren
FOFrancisco Javier Ortiz-López
Francisco Javier Ortiz-López
TJTue Sparholt Jørgensen
Tue Sparholt Jørgensen
Daniel Carretero-MolinaDaniel Carretero-Molina
Daniel Carretero-Molina
TWTilmann Weber
Tilmann Weber
Streptomyces are well-known producers of a range of different secondary metabolites, including antibiotics and other bioactive compounds. Recently, it has been demonstrated that “silent” biosynthetic gene clusters (BGCs) can be activated by heterologously expressing transcriptional regulators from other BGCs. Here, we have activated a silent BGC in Streptomyces sp. CA-256286 by overexpression of a set of SARP family transcriptional regulators. The structure of the produced compound was elucidated by NMR and found to be an N-acetyl cysteine adduct of the pyranonaphtoquinone polyketide 3′-O-α-d-forosaminyl-(+)-griseusin A. Employing a combination of multi-omics and metabolic engineering techniques, we identified the responsible BGC. These methods include genome mining, proteomics and transcriptomics analyses, in combination with CRISPR induced gene inactivations and expression of the BGC in a heterologous host strain. This work demonstrates an easy-to-implement workflow of how silent BGCs can be activated, followed by the identification and characterization of the produced compound, the responsible BGC, and hints of its biosynthetic pathway.

10 May 2023 in Organic Letters
Verified
Journal Article
Closed access
FOFrancisco Javier Ortiz-López
Francisco Javier Ortiz-López
DODaniel Oves-Costales
Daniel Oves-Costales
Daniel Carretero-MolinaDaniel Carretero-Molina
Daniel Carretero-Molina
JMJesús Martín
Jesús Martín
CDCaridad Díaz
Caridad Díaz
OGOlga Genilloud
Olga Genilloud

8 January 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
FRFernando Román-Hurtado
Fernando Román-Hurtado
MSMarina Sánchez-Hidalgo
Marina Sánchez-Hidalgo
JSJesús Martín Serrano
Jesús Martín Serrano
FOFrancisco Javier Ortiz-López
Francisco Javier Ortiz-López
Daniel Carretero-MolinaDaniel Carretero-Molina
Daniel Carretero-Molina
OGOlga Genilloud
Olga Genilloud
The strain Streptomyces cacaoi CA-170360 produces the cyclic pentapeptides pentaminomycins A–H and BE-18257 A–C, two families of cyclopeptides synthesized by two non-ribosomal peptide synthetases encoded in tandem within the same biosynthetic gene cluster. In this work, we have cloned and confirmed the heterologous expression of this biosynthetic gene cluster, demonstrating that each of the non-ribosomal peptide synthetases present in the cluster is involved in the biosynthesis of each group of cyclopeptides. In addition, we discuss the involvement of a stand-alone enzyme belonging to the Penicillin Binding Protein family in the release and macrocyclization of the peptides.

1 April 2021 in Journal of Natural Products
Verified
Journal Article
Closed access
Daniel Carretero-MolinaDaniel Carretero-Molina
Daniel Carretero-Molina
FOFrancisco Javier Ortiz-López
Francisco Javier Ortiz-López
JMJesús Martín
Jesús Martín
IGIgnacio González
Ignacio González
MSMarina Sánchez-Hidalgo
Marina Sánchez-Hidalgo
Fernando ReyesFernando Reyes
Fernando Reyes